SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : EXTI - only public co. developing liver device
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: CENTrader who wrote (177)2/13/1998 4:50:00 AM
From: Shawn Donahue  Read Replies (2) of 1063
 
Bill,

Thanks for the link to that FDA article...Do you know if
anyone at Exten is aware of this announcement and if they
will take specific action to apply to the FDA for special
treatment as an experimental therapy for treating liver
disease? I would think that the FDA in addition to the
private medical community would want to expidite any chance
of a cure for liver disease or a prolonging of a life so
that a liver can be found for transplanting!I'm talking
specifically about this part of that November announcement:

" -- Clinical trial data banks. The bill sets up a national
data bank on clinical trials for serious diseases. It would
help find experimental therapies for patients without
comparable treatment."

As far as your comment about "keeping faith" I keep my faith
in God where it belongs and not in stocks! But I understand
your message to imply that patience is needed to fully realize
the appreciation that this stock will bring for those who buy
now and hold...$$$$!I buy stocks based on the fundamentals, as
I'm sure most of you do and Management definitely looks very good
based on what you dug up on how successful the EXTI CEO has been
in other endeavors (I must compliment your research skills as I
have clicked on most of your links for other stock postings and
you seem to find things that others miss!), and Danny's
Bio on EXTI in the beginning of this folder addresses the viability
of the technology and of course the medical expertise keeps getting
better with more Liver Research advisors being added on a regular
basis and trials set to begin soon...So I did the prudent thing
and bought a majority of today's volume before it runs up beyond
.17 again. And I will probably add to that as we get further along
in the clinical trials... Thanks to you and Danny and others that
make a difference by reporting what they have researched!

Shawn
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News